GILEAD SCIENCES, INC.
Latest Filing: May 7, 2026 • 25 Total Filings
Total Assets
2026
$56.28B
Total Revenue
2026
$6.96B
Net Income
2026
$2.02B
Operating Cash Flow
2026
$2.54B